key: cord-0787857-25jzxcpw authors: Velavan, Thirumalaisamy P.; Meyer, Christian G. title: Reply to: Asymptomatic infection by SARS 2 coronavirus: invisible but invincible date: 2020-10-17 journal: Int J Infect Dis DOI: 10.1016/j.ijid.2020.10.034 sha: 4264b65c035f893e102b809745cdfa0cff8a0cea doc_id: 787857 cord_uid: 25jzxcpw nan Malagón-Rojas et al. comments on the need for a widely accepted definition of asymptomatic carriers and pre-symptomatic patients and to report asymptomatic individuals in official COVID-19 statistics are well acknowledged (Nikolai et al. 2020 (Zhou et al. 2020 ). Long-term virus shedding was documented rather in asymptomatic than in symptomatic patients and virus shedding did not correspond to viral infectivity (Long et al. 2020) . We agree with the authors that the absence of respiratory symptoms such as sneezing or coughing limits the potential of spread by asymptomatic individuals, however, virus transmission may occur through occasional and also more frequent sneezing during the allergy season may also increase the risk (Busco et al. 2020). The risk still exists. Asymptomatic and presymptomatic stages can currently be assigned only retrospectively, namely after the occurrence or non-occurrence of clinical symptoms and it is virtually impossible to accurately determine the extent of asymptomatic infections. The true incidence of asymptomatic infections can only be determined if closest surveillance and extensive testing is installed and continued for a period of time exceeding the estimated average incubation period of at least five days in order not to miss a possible onset of symptoms (Nikolai et al. 2020) . Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections Asymptomatic SARS Coronavirus 2 infection: Invisible yet invincible A Systematic Review of the Clinical Utility of Cycle Threshold Values in the Context of COVID-19 Epidemiologic Features and Clinical Course of Patients Infected With SARS-CoV-2 in Singapore Viral dynamics in asymptomatic patients with COVID-19